OZEM Among Its Peers
End-of-day Nov 20, 2026 · 0 ETFs by 3Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.9% | −8.5% | −4.1% | −15.1% | −15.8% | −10.5% | — | — | — | +14.9% |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$203 of every $1,000 in OZEM is Eli
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | Eli Lilly & | 20.25% |
| 2 | NVO | Novo Nordisk A/S | 10.81% |
| 3 | 4519.T | Chugai Pharmaceutical | 7.36% |
| 4 | 128940.KS | Hanmi Pharm | 6.77% |
| 5 | PFE | Pfizer | 5.78% |
| 6 | 1093.HK | CSPC Pharmaceutical Group | 5.02% |
| 7 | KLRA | Kailera Therapeutics | 4.55% |
| 8 | 1276.HK | Jiangsu Hengrui Pharmaceuticals | 4.07% |
| 9 | 3692.HK | Hansoh Pharmaceutical Group | 3.79% |
| 10 | VKTX | Viking Therapeutics | 3.72% |
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly | Healthcare | 20.25% | $2,025.45 | 8,083 | $10.9M |
| 2 | NVONovo Nordisk A/S | Healthcare | 10.81% | $1,080.59 | 150K | $5.8M |
| 3 | 4519.TChugai Pharmaceutical | Healthcare | 7.36% | $736.14 | 87K | $4.0M |
| 4 | 128940.KSHanmi Pharm | Healthcare | 6.77% | $676.84 | 12K | $3.6M |
| 5 | PFEPfizer | Healthcare | 5.78% | $578.17 | 113K | $3.1M |
| 6 | 1093.HKCSPC Pharmaceutical Group | Healthcare | 5.02% | $502.37 | 2.6M | $2.7M |
| 7 | KLRAKailera Therapeutics | Healthcare | 4.55% | $454.51 | 212K | $2.5M |
| 8 | 1276.HKJiangsu Hengrui Pharmaceuticals | Healthcare | 4.07% | $407.21 | 380K | $2.2M |
| 9 | 3692.HKHansoh Pharmaceutical Group | Healthcare | 3.79% | $378.66 | 494K | $2.0M |
| 10 | VKTXViking Therapeutics | Healthcare | 3.72% | $371.76 | 78K | $2.0M |
| 11 | 1672.HKAscletis Pharma | Healthcare | 3.36% | $335.71 | 3.2M | $1.8M |
| 12 | AZNAstraZeneca | Healthcare | 3.26% | $326.16 | 10K | $1.8M |
| 13 | AMGNAmgen | Healthcare | 2.98% | $298.50 | 3,689 | $1.6M |
| 14 | ZEAL.COZealand Pharma A/S | Healthcare | 2.91% | $291.28 | 50K | $1.6M |
| 15 | ROP.SWRoche AG | Healthcare | 2.82% | $282.20 | 3,213 | $1.5M |
OZEM has no close peers in our data yet: […]
No peers with a full year of prices to rank against yet.
| Fund | Sharpe | Sortino | Volatility | Max DD | Beta | Fee / $10k |
|---|---|---|---|---|---|---|
| OZEM | −0.57 | −0.84 | 23.4% | −22.4% | 0.76 | $59 |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 30, 2025 | Dec 31, 2025 | $0.41 |
| Dec 30, 2024 | Dec 31, 2024 | $0.0531 |